The Effect of Anakinra on Insulin Secretion

Status Active, not recruiting

Clinical Trial Summary

Rationale: Once diabetes develops, β-cell function progressively deteriorates and therapeutic approaches that prevent of delay loss of β-cell function are needed in the treatment of type 2 diabetes mellitus. Recent findings suggest that interleukin-1 (IL-1) may be involved in the progressive β-cell dysfunction in type 2 diabetes mellitus.

Objective: to determine whether blocking IL-1β by recombinant human IL-1ra (anakinra) improves beta-cell function in subjects with β-cell dysfunction.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01285232
Study type	Interventional
Source	Radboud University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2011
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01267448` - Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia	Phase 4
Active, not recruiting	`NCT05330247` - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study	N/A
Terminated	`NCT02743598` - Liraglutide for HIV-associated Neurocognitive Disorder	Phase 4
Terminated	`NCT02373865` - Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT01741181` - Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2	Phase 4
Completed	`NCT01305434` - Mulberry Leaf Extract and Blood Glucose Control in Diabetics	Phase 1/Phase 2
Completed	`NCT01330121` - Bridging the Gap by Transitional Care	N/A
Recruiting	`NCT00992797` - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity	Phase 2
Completed	`NCT01580904` - Impact of Pharmaceutical Care in Diabetics Patients	N/A
Active, not recruiting	`NCT00728403` - Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes	Phase 2
Completed	`NCT00763815` - GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone	Phase 3
Active, not recruiting	`NCT00529815` - Continuous Glucose Monitoring in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT00517465` - A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.	Phase 1
Completed	`NCT00119041` - Diabetes Telemedicine Consultation: A Systems Improvement Intervention	N/A
Withdrawn	`NCT00417716` - Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema	Phase 3
Withdrawn	`NCT00600236` - HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population	Phase 3
Active, not recruiting	`NCT05887635` - Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus	N/A
Completed	`NCT03903965` - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed	`NCT02666924` - Cooking Classes for Chinese Canadian Patients Living With Diabetes	N/A
Recruiting	`NCT02501850` - The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)	Phase 4